HOYA Corporation (TYO:7741)
Japan · Delayed Price · Currency is JPY 22,140
+15 (0.07%)
Oct 17, 2025, 3:30 PM JST
HOYA Corporation Revenue
HOYA Corporation had revenue of 220.88 billion JPY in the quarter ending June 30, 2025, with 3.33% growth. This brings the company's revenue in the last twelve months to 876.09 billion, up 10.33% year-over-year. In the fiscal year ending March 31, 2025, HOYA Corporation had annual revenue of 866.03 billion with 13.56% growth.
Revenue (ttm)
876.09B
Revenue Growth
+10.33%
P/S Ratio
8.60
Revenue / Employee
23.11M
Employees
37,909
Market Cap
7,535.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 866.03B | 103.42B | 13.56% |
| Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
| Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
| Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
| Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4,480.25B |
| Otsuka Holdings | 2,401.70B |
| Astellas Pharma | 1,944.99B |
| Daiichi Sankyo Company | 1,924.68B |
| Chugai Pharmaceutical | 1,196.21B |
| Terumo | 1,037.94B |
| Olympus | 969.02B |
| Eisai | 803.02B |